ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ZJYL vs SMTI // 10Y YIELD & FRED MACRO BETA

JIN MEDICAL INTERNATIONAL LTD. (Class A) (NASDAQ) VS. Sanara MedTech Inc. (NASDAQ) • 15-METRIC TALLY: ZJYL 1 — SMTI 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZJYL VS. SMTI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ZJYL SMTI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 29.20% 92.70% -63.50 SMTI /gross-margins <GO>
Return on Invested Capital (ROIC) — 16.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation 47.1x 29.5x +17.60 SMTI /valuation <GO>
Free Cash Flow Yield -1.27% 0.71% -1.98 SMTI /fcf-yield <GO>
Operating Margin 2.90% 7.10% -4.20 SMTI /operating-margins <GO>
Net Profit Margin 5.80% 36.40% -30.60 SMTI /net-margins <GO>
Revenue Growth (YoY) -12.00% 19.00% -31.00 SMTI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 3.25 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 7/9 -3.00 SMTI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.0 27.3 +33.62 ZJYL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 6.8x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $294.2M $302.4M -$8.2M SMTI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ZJYL REV SMTI REV ZJYL GROSS % SMTI GROSS % ZJYL FCF SMTI FCF
FY 2025 $20.7M $103.1M 29.2% 92.7% -$3.7M $2.2M
FY 2024 $23.5M $86.7M 40.4% 90.6% -$1.4M -$229.6K
FY 2023 $19.8M $65.0M — — $3.1M -$3.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZJYL // BETA —
SMTI // BETA —